back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-05-20 12:18 Tx date 2025-05-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$305,502
+37,485 vol $8.15 each |
85,085 | |
| Filed 2024-11-26 11:12 Tx date 2024-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+12,135 vol |
12,135 | |
| Filed 2024-11-26 11:11 Tx date 2024-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$153,601
+18,641 vol $8.24 each |
47,600 | |
| Filed 2024-11-13 13:27 Tx date 2024-11-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+13,356 vol |
13,356 | |
| Filed 2024-11-13 13:26 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-13 13:25 Tx date 2024-11-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-17,913 vol |
0 | |
| Filed 2023-08-22 14:13 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+17,913 vol |
17,913 | |
| Filed 2023-08-22 14:12 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-22 14:11 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$274,820
+28,959 vol $9.49 each |
28,959 | |
| Filed 2023-08-22 14:08 Tx date 2023-08-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|